We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPB:NYSESpectrum Brands Holdings, Inc. Analysis

Data as of 2026-08-02 - not real-time

$88.77

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Spectrum Brands is trading near the midpoint of its recent support and resistance band, with the short‑term moving average comfortably above the medium‑term average and both above the long‑term trend line, underscoring a bullish bias. The relative strength index sits in a neutral zone, while the MACD histogram has turned slightly negative, suggesting modest short‑term pressure but no imminent reversal. Fundamentally, the company shows modest revenue growth, solid free cash flow, and a dividend yield that comfortably exceeds the risk‑free rate, with a payout ratio well below the sustainability threshold. Recent material news highlights a strategic partnership that could unlock value in the underperforming home‑and‑personal‑care segment, adding a catalyst for a potential re‑rating. Valuation metrics point to a price well below discounted cash‑flow estimates, indicating a notable margin of safety for patient investors.
Given the defensive consumer sector positioning, low beta, and attractive dividend, the stock presents a compelling blend of value and growth characteristics for medium to long‑term horizons, while short‑term traders may adopt a cautious hold stance pending confirmation of momentum.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • MACD histogram turning negative
  • Decreasing volume trend
  • Price near mid‑range of support/resistance

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic partnership unlocking segment value
  • Undervaluation relative to DCF
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Defensive consumer‑staples positioning
  • Consistent free cash flow generation
  • Low beta and attractive dividend yield

Key Metrics & Analysis

Financial Health

Revenue Growth4.90%
Profit Margin4.47%
P/E Ratio17.3
ROE6.64%
ROA2.87%
Debt/Equity38.17
P/B Ratio1.1
Op. Cash Flow$330.5M
Free Cash Flow$222.4M

Technical Analysis

TrendBullish
RSI57.1
Support$80.77
Resistance$91.42
MA 20$86.92
MA 50$83.90
MA 200$72.00
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Fair Value$126.76
Target Price$88.00
Upside/Downside-0.87%
GradeUndervalued
TypeBlend
Dividend Yield2.12%

Risk Assessment

Beta0.67
Volatility28.93%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.